Previous 10 | Next 10 |
-- NUZYRA® (omadacycline) Generated Net U.S. Sales of $26.2 Million from the Core Commercial Business, a 32% Increase Over First Quarter 2022 -- Company Reiterates Full-Year Revenue Guidance of $143 to $158 Million -- Announces Full-Year R&D and SG&A Expense Guidanc...
2023-05-08 17:35:56 ET Major earnings expected after the bell on Tuesday include: Airbnb ( ABNB ) Occidental Petroleum Corporation ( OXY ) Twilio ( TWLO ) Virgin Galactic Holdings ( SPCE ) Upstart Holdings ( UPST ) For further details see: ...
2023-05-02 10:20:56 ET Jefferies has initiated Paratek Pharmaceuticals ( NASDAQ: PRTK ) with a buy rating saying that it is poised to benefit from its growing antibiotics franchise. The firm set a price target of $5 (~216% upside based on Monday's close). Analyst Kambiz Ya...
BOSTON, May 01, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Tuesday, May 9 at 4:30 p.m. EDT to report financial results for first quarter 2023. The audio webcast can be accessed un...
2023-04-24 13:32:35 ET Gainers: IN8bio ( INAB ) +211% . EUDA Health Holdings Limited ( EUDA ) +50% . Getty Images Holdings ( GETY ) +36% . IDEAYA Biosciences ( IDYA ) +24% . NextPlat Corp ( NXPL ) +23% . Mangoceuticals ( MG...
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, governm...
2023-03-31 10:05:49 ET Gainers: Y-mAbs Therapeutics ( YMAB ) +43% . G Medical Innovations ( GMVD ) +41% . Palisade Bio ( PALI ) +20% . Inozyme Pharma ( INZY ) +17% . Paratek Pharmaceuticals ( PRTK ) +17% . Losers: Pyxis...
2023-03-31 08:22:14 ET Digital World Acquisition ( DWACW ) +37% . Palisade Bio ( PALI ) +30% . G Medical Innovations Holdings ( GMVD ) +19% . Pineapple Energy ( PEGY ) +19% Q4 earnings call release Metropolitan Bank Holding (...
2023-03-30 05:50:04 ET Paratek Pharmaceuticals ( NASDAQ: PRTK ) announced that Highland Capital Management purchased $1.3M worth company's shares. The purchase was conducted in multiple transactions at different prices. Shares trading 1% higher premarket. Fo...
2023-03-21 13:17:27 ET Paratek Pharmaceuticals ( NASDAQ: PRTK ) is up 20% in Tuesday afternoon trading amid a report that the biopharma is a takeout target. Betaville Intelligence is reporting that those familiar with the situation say a private equity firm is the ...
News, Short Squeeze, Breakout and More Instantly...
Paratek Pharmaceuticals Inc. Company Name:
PRTK Stock Symbol:
NASDAQ Market:
Paratek Pharmaceuticals Inc. Website:
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Paratek Pharmaceuticals Inc. (PRTK) is expected to report $-0.25 for Q3 2023
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military ...